02Feb 2018

SAFETY ASSESSMENT OF PARTIALLY PURIFIED HDL ENHANCING PHYTOCOMPONENTS FROM DESMODIUM GYRANS DC.

  • Department of Biochemistry, Amala Cancer Research Centre, Amala Nagar, Thrissur - 680 555, Kerala, India.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Desmodium gyrans (Fabaceae) is a less explored plant belonging to medicinally important genera Desmodium. A recent investigation has reported hypolipidemic and HDL enhancing efficacy of crude alcoholic extract (DGM) of the whole plant. Chromatographically purified aqueous fraction (DGMAF) rich in terpenoids and phenolics exhibited HDL enhancing and reverse cholesterol transport (RCT) promoting activity that may impart atheroprotective potential to this active fraction. Present study was aimed to evaluate the acute and sub-acute oral toxicity of DGMAF in Wistar rats of either sex following OECD guide lines to ensure its safety upon long term exposure. Acute oral dose of 5g/kg body weight did not produce any behavioural abnormality, weight changes or mortality over 14 day period. Necropsy studies revealed no incongruity to internal organs. Further, oral sub-acute doses of 100, 250, and 500 mg/kg body wt for 60 days did not show reduction in body and organ weight, food and water intake. Hematological parameters and biochemical analytes inclusive of hemoglobin, urea, creatinine, total and direct bilirubin, serum GOT, GPT, and ALP did not show statistically significant differences between the untreated control and treated groups. No morphological changes were observed in the histological analysis of the major vital organs including liver, kidney, spleen and intestine. The result of this study thus suggests that DGMAF might be non-toxic at normal therapeutic doses.


  1. Akhila JS, Shyamjith D, Alwar MC (2007). Acute toxicity studies and determination of median lethal dose. Sci.93: 917 ? 920.
  2. Alam MB, Chowdhury NS, Mazumder MEH, Haque ME (2011). In vitro and in vivo antioxidant and toxicity evaluation of different fractions of Oxalis corniculata linn. Toxicol. 6: 337-348.
  3. Boyd JP (1966). Organ weights and water levels of the rat following reduced food intake. J 90: 354?360.
  4. Busari MB, Ogbadoyi EO, Kabiru AY, Sani S, Yusuf RS (2015). In vivo evaluation of antidiabetic properties of seed oil of Moringa oleifera Lam. J Appl Life Sci Int.2: 160-174.
  5. Chavda RVK, Gokani R. (2010). Hepatoprotective and antioxidant activity of root bark of Calotropis procera R.Br (Asclepediaceae). Int J Pharmacol. 6: 937-943.
  6. Drabkin DL (1932). Spectrometric studies; spectrometric constants for common haemoglobin derivatives in human, dog and rabbit blood. J Biol Chem. 98: 719?733.
  7. Fragoso LR, Brirchiel SW, Ruiz DH, Torres E. (2008). Risks and benefits of commonly used herbal medicines in Mexico. Appl Pharmacol. 22: 125?351.
  8. Hamid Rhiouani J, Zafar H. Israili, Badiaa Lyoussia. J (2008). Acute and subchronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents. 118:378?386.
  9. Hayes A (1987). Guidelines of Acute Oral Toxicity Testing. 2nd Ed. Raven Press Ltd., New York, 185.
  10. OECD (2000). Environment, Health and Safety Publications Series on Testing and Assessment No 24 guidance document on acute oral toxicity testing.
  11. OECD (2001). OECD Guidance Document on Acute Oral Toxicity Testing. Organization for EconomicCo-operation and Development: Paris, France
  12. Park MC, Kim J, Lee H, Ku S (2010). 28 days repeated oral dose toxicity test of aqueous extracts of Mahwangyounpae-tang, a polyherbal formula. Food 48: 2477?2482.
  13. C (1968). A mathematical evaluation of the thymic weight parameter.Toxicol. Appl Pharmacol. 13: 220-227.
  14. Rhiouani H, El-Hilaly J, Israili Z H and Lyoussi B (2008). Acute and sub-chronic toxicity of an aqueous extract of the leaves of Herniaria glabra in rodents. Journal of Ethnopharmacol. 118:378-386.
  15. Robinson S, Stei P and Dreher D (2007). Challenging the regulatory requirement for conventional acute toxicity studies in pharmaceutical drug development. Appl Pharmacol. 231: 296.
  16. Vipin P.S, Seema Menon, Lincy Lawrence, Achuthan C. Raghavamenon and Jose Padikkala. (2015). Enhancement of functional HDL contributing to anti-atherogenic efficacy of Desmodium gyrans DC. 4: 2278 ? 4357.

[M. S. Indu, Jose Padikkala and Achuthan C Raghavamenon. (2018); SAFETY ASSESSMENT OF PARTIALLY PURIFIED HDL ENHANCING PHYTOCOMPONENTS FROM DESMODIUM GYRANS DC. Int. J. of Adv. Res. 6 (Feb). 210-217] (ISSN 2320-5407). www.journalijar.com


Achuthan C. Raghavamenon
Dept. of Biochemistry, Amala Cancer Research Centre, Thrissur

DOI:


Article DOI: 10.21474/IJAR01/6430      
DOI URL: http://dx.doi.org/10.21474/IJAR01/6430